EDP Sciences logo
Subscriber Authentication Point
Search
Menu
Home All issues Volume 19 / No 2 (Février 2003) Med Sci (Paris), 19 2 (2003) 131 References
Free Access
Editorial
Issue
Med Sci (Paris)
Volume 19, Number 2, Février 2003
Page(s) 131 - 131
Section Éditorial
DOI https://doi.org/10.1051/medsci/2003192131
Published online 15 February 2003
  1. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000; 100: 57–70. [Google Scholar]
  2. Suzuki T, Shen H, Akagi K, et al. New genes involved in cancer identified by retrovirus tagging. Nat Genet 2002; 32: 166–74. [Google Scholar]
  3. Douillard JY, Cunningham D, Roth AD, et al. Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic cancer: a multicentre randomised trial. Lancet 2000; 355: 1041–7. [Google Scholar]
  4. Slamon DJ, Leyland-Jones B, Shak S, et al. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N Engl J Med 2001; 344: 783–92. [Google Scholar]
  5. Druker BJ, Talpaz M, Resta DJ, et al. Efficacy and safety of a specific inhibitor of the BCR/ABL tyrosine kinase in chronic myeloid leukemia. N Engl J Med 2001; 344: 1031–7. [Google Scholar]
  6. Pommier Y, YU Q, Kohn KW. Novel targets in the cell cycle and cell cycle checkpoints. In: Baguley BC, Kerr DJ, eds. Anticancer drug development. San Diego: Academic Press, 2002 : 13–30. [Google Scholar]
  7. Hunter T. Signaling: 2000 and beyond. Cell 2000; 100: 113–27. [Google Scholar]
  8. Scheijen B, Griffin JD. Tyrosine kinase oncogenes in normal hematopoiesis and hematological disease. Oncogene 2002; 21: 3314–33. [Google Scholar]
  9. Giaccone G, Johnson DH, Manegold C, et al. A phase III clinical trial of ZD1839 (Iressa) in combination with gemcitabine and cisplatin in chemotherapy-naive patients with advanced non-small-cell lung cancer (INTACT 1). Ann Oncol 2002; 13 (suppl 5): 2–3. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.